Katarzyna Kulig

1.2k total citations
81 papers, 1.0k citations indexed

About

Katarzyna Kulig is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Katarzyna Kulig has authored 81 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 33 papers in Organic Chemistry and 29 papers in Cellular and Molecular Neuroscience. Recurrent topics in Katarzyna Kulig's work include Neuroscience and Neuropharmacology Research (24 papers), Analytical Chemistry and Chromatography (14 papers) and Computational Drug Discovery Methods (12 papers). Katarzyna Kulig is often cited by papers focused on Neuroscience and Neuropharmacology Research (24 papers), Analytical Chemistry and Chromatography (14 papers) and Computational Drug Discovery Methods (12 papers). Katarzyna Kulig collaborates with scholars based in Poland, Germany and United States. Katarzyna Kulig's co-authors include Barbara Malawska, Kinga Sałat, Barbara Filipek, Jacek Sapa, Anna Jakubowska, Alicja Nowaczyk, Adrian Podkowa, Dorota Maciąg, Klaus T. Wanner and Georg Höfner and has published in prestigious journals such as Journal of Chromatography A, Tetrahedron and European Journal of Pharmacology.

In The Last Decade

Katarzyna Kulig

77 papers receiving 1.0k citations

Peers

Katarzyna Kulig

CMN

PHYSI

SPECT

Elena Poggesi Italy

Anna M. Waszkielewicz Poland

Norman Huebert United States

Anna Rapacz Poland

Joseph H. Krushinski United States

Maria João Bonifácio Portugal

Giuseppe Ronsisvalle Italy

Christoph A. Seyfried Germany

Katalin Prókai-Tátrai United States

Bindi Sohal United Kingdom

Elena Poggesi Italy

Katarzyna Kulig

746 ×2.0

484 ×1.5

CMN

347 ×1.1

215 ×1.2

PHYSI

54 ×0.4

SPECT

Citations per year, relative to Katarzyna Kulig Katarzyna Kulig (= 1×) peers Elena Poggesi

Countries citing papers authored by Katarzyna Kulig

Since Specialization

Citations

This map shows the geographic impact of Katarzyna Kulig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarzyna Kulig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarzyna Kulig more than expected).

Fields of papers citing papers by Katarzyna Kulig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarzyna Kulig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarzyna Kulig. The network helps show where Katarzyna Kulig may publish in the future.

Co-authorship network of co-authors of Katarzyna Kulig

This figure shows the co-authorship network connecting the top 25 collaborators of Katarzyna Kulig. A scholar is included among the top collaborators of Katarzyna Kulig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarzyna Kulig. Katarzyna Kulig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kulig, Katarzyna, et al.. (2024). GW0742 as a Potential TRα and TRβ Antagonist Reduces the Viability and Metabolic Activity of an Adult Granulosa Tumour Cell Line and Simultaneously Upregulates TRβ Expression. Cancers. 16(23). 4069–4069. 2 indexed citations

Zaręba, Paula, Kinga Sałat, Georg Höfner, et al.. (2021). Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity. European Journal of Medicinal Chemistry. 221. 113512–113512. 11 indexed citations

Zaręba, Paula, Kinga Sałat, Georg Höfner, et al.. (2019). Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice. European Journal of Medicinal Chemistry. 188. 111920–111920. 13 indexed citations

Kotańska, Magdalena, et al.. (2017). Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist. Journal of Endocrinological Investigation. 41(5). 609–619. 8 indexed citations

Sałat, Kinga, et al.. (2016). Search for new potential anticonvulsants with anxiolytic and antidepressant properties among derivatives of 4,4-diphenylpyrrolidin-2-one. Pharmacological Reports. 69(1). 105–111. 6 indexed citations

Sałat, Kinga, Adrian Podkowa, Szczepan Mogilski, et al.. (2015). The effect of GABA transporter 1 (GAT1) inhibitor, tiagabine, on scopolamine-induced memory impairments in mice. Pharmacological Reports. 67(6). 1155–1162. 33 indexed citations

Sałat, Kinga, Anna Jakubowska, & Katarzyna Kulig. (2015). Cebranopadol: a first-in-class potent analgesic agent with agonistic activity at nociceptin/orphanin FQ and opioid receptors. Expert Opinion on Investigational Drugs. 24(6). 837–844. 18 indexed citations

Sałat, Kinga, Anna Jakubowska, & Katarzyna Kulig. (2014). Zucapsaicin for the treatment of neuropathic pain. Expert Opinion on Investigational Drugs. 23(10). 1433–1440. 26 indexed citations

Sałat, Kinga, Adrian Podkowa, Katarzyna Kulig, et al.. (2014). Anticonvulsant active inhibitor of GABA transporter subtype 1, tiagabine, with activity in mouse models of anxiety, pain and depression. Pharmacological Reports. 67(3). 465–472. 55 indexed citations

10.

Kulig, Katarzyna, et al.. (2010). Synthesis and pharmacological evaluation of pyrrolidin-2-one derivatives as antiarrhythmic, antihypertensive and α-adrenolytic agents. Pharmacological Reports. 62(1). 68–85. 12 indexed citations

11.

Kulig, Katarzyna, et al.. (2009). Synthesis of 3,3- and 4,4-Alkyl-phenyl-substituted Pyrrolidin-2-one Derivatives. Polish Journal of Chemistry. 83(9). 1629–1636. 6 indexed citations

12.

Kulig, Katarzyna, Jacek Sapa, Alicja Nowaczyk, Barbara Filipek, & Barbara Malawska. (2009). Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and α-adrenolytic activity. European Journal of Medicinal Chemistry. 44(10). 3994–4003. 26 indexed citations

13.

Kulig, Katarzyna, et al.. (2008). The Role of Structure Activity Relationship Studies in the Search for New GABA Uptake Inhibitors. Mini-Reviews in Medicinal Chemistry. 8(12). 1214–1223. 10 indexed citations

14.

Malawska, Barbara & Katarzyna Kulig. (2008). Brivaracetam: a new drug in development for epilepsy and neuropathic pain. Expert Opinion on Investigational Drugs. 17(3). 361–369. 21 indexed citations

15.

Kulig, Katarzyna, et al.. (2008). Application of RP‐TLC technique for the determination of dissociation constants of 1‐substituted pyrrolidin‐2‐one derivatives. Biomedical Chromatography. 22(11). 1225–1229. 3 indexed citations

16.

Kulig, Katarzyna, Piotr Nowicki, & Barbara Malawska. (2007). Synthesis of the enantiomers of 1-{2 -hydroxy -3 -[4 -(2 -hydroxy -phenyl ) -piperazin -1 -yl ]-propyl}-pyrrolidin-2-one using soluble and polystyrene bound salenco(III)OAc complexes as catalysts of hydrolytic kinetic resolution. Polish Journal of Chemistry. 81(2). 179–186. 3 indexed citations

17.

Kulig, Katarzyna & Barbara Malawska. (2006). Estimation of phospholipophilicity of 1‐[3‐(arylpiperazin‐1‐yl)‐propyl]‐pyrrolidin‐2‐one derivatives on immobilized artificial membrane stationary phase and its correlation with biological data. Biomedical Chromatography. 20(11). 1129–1135. 2 indexed citations

18.

Malawska, Barbara, et al.. (2003). Investigation into new anticonvulsant derivatives of α-substituted N-benzylamides of γ-hydroxy- and γ-acetoxybutyric acid. Part 5: Search for new anticonvulsant compounds. Bioorganic & Medicinal Chemistry. 12(3). 625–632. 30 indexed citations

19.

Kulig, Katarzyna & Barbara Malawska. (2003). Estimation of the lipophilicity of antiarrhythmic and antihypertensive active 1‐substituted pyrrolidin‐2‐one and pyrrolidine derivatives. Biomedical Chromatography. 17(5). 318–324. 14 indexed citations

20.

Malawska, Barbara, et al.. (1999). Synthesis, Physicochemical Properties, Anticonvulsant Activities, and GABA-ergic and Voltage-sensitive Calcium Channel Receptor Affinities of α-SubstitutedN-Benzylamides of γ-Hydroxybutyric Acid Part 4: Search for New Anticonvulsant Compounds. Archiv der Pharmazie. 332(5). 167–174. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact